Compare XBIT & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | TWIN |
|---|---|---|
| Founded | 2005 | 1918 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.8M | 269.7M |
| IPO Year | 2015 | 1994 |
| Metric | XBIT | TWIN |
|---|---|---|
| Price | $2.26 | $22.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.6K | ★ 188.8K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.76 |
| Revenue | N/A | ★ $340,738,000.00 |
| Revenue This Year | N/A | $10.79 |
| Revenue Next Year | N/A | $8.43 |
| P/E Ratio | ★ N/A | $12.81 |
| Revenue Growth | N/A | ★ 15.45 |
| 52 Week Low | $2.09 | $8.03 |
| 52 Week High | $3.61 | $24.50 |
| Indicator | XBIT | TWIN |
|---|---|---|
| Relative Strength Index (RSI) | 36.79 | 53.14 |
| Support Level | $2.18 | $14.60 |
| Resistance Level | $2.42 | $24.16 |
| Average True Range (ATR) | 0.05 | 1.31 |
| MACD | -0.00 | -0.21 |
| Stochastic Oscillator | 7.49 | 30.74 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.